Matches in Wikidata for { <http://www.wikidata.org/entity/Q103004078> ?p ?o ?g. }
- Q103004078 description "2020 nî lūn-bûn" @default.
- Q103004078 description "2020 թվականի նոյեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q103004078 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 10ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q103004078 description "2020年の論文" @default.
- Q103004078 description "2020年学术文章" @default.
- Q103004078 description "2020年学术文章" @default.
- Q103004078 description "2020年学术文章" @default.
- Q103004078 description "2020年学术文章" @default.
- Q103004078 description "2020年学术文章" @default.
- Q103004078 description "2020年学术文章" @default.
- Q103004078 description "2020年學術文章" @default.
- Q103004078 description "2020年學術文章" @default.
- Q103004078 description "2020年學術文章" @default.
- Q103004078 description "2020年學術文章" @default.
- Q103004078 description "2020年學術文章" @default.
- Q103004078 description "2020년 논문" @default.
- Q103004078 description "article científic" @default.
- Q103004078 description "article scientific" @default.
- Q103004078 description "article scientifique" @default.
- Q103004078 description "articol științific" @default.
- Q103004078 description "articolo scientifico" @default.
- Q103004078 description "artigo científico" @default.
- Q103004078 description "artigo científico" @default.
- Q103004078 description "artigo científico" @default.
- Q103004078 description "artikel ilmiah" @default.
- Q103004078 description "artikull shkencor" @default.
- Q103004078 description "artikulong pang-agham" @default.
- Q103004078 description "artykuł naukowy" @default.
- Q103004078 description "artículo científico publicado en 2020" @default.
- Q103004078 description "artículu científicu" @default.
- Q103004078 description "bilimsel makale" @default.
- Q103004078 description "bài báo khoa học" @default.
- Q103004078 description "naučni članak" @default.
- Q103004078 description "scienca artikolo" @default.
- Q103004078 description "scientific article published on 10 November 2020" @default.
- Q103004078 description "scientific article published on 10 November 2020" @default.
- Q103004078 description "scientific article published on 10 November 2020" @default.
- Q103004078 description "teaduslik artikkel" @default.
- Q103004078 description "tieteellinen artikkeli" @default.
- Q103004078 description "tudományos cikk" @default.
- Q103004078 description "vedecký článok" @default.
- Q103004078 description "vetenskaplig artikel" @default.
- Q103004078 description "videnskabelig artikel udgivet 10. november 2020" @default.
- Q103004078 description "vitenskapelig artikkel" @default.
- Q103004078 description "vitskapeleg artikkel" @default.
- Q103004078 description "vědecký článek" @default.
- Q103004078 description "wetenschappelijk artikel" @default.
- Q103004078 description "wissenschaftlicher Artikel" @default.
- Q103004078 description "επιστημονικό άρθρο" @default.
- Q103004078 description "мақолаи илмӣ" @default.
- Q103004078 description "наукова стаття, опублікована в листопаді 2020" @default.
- Q103004078 description "научна статия" @default.
- Q103004078 description "научная статья" @default.
- Q103004078 description "научни чланак" @default.
- Q103004078 description "научни чланак" @default.
- Q103004078 description "מאמר מדעי" @default.
- Q103004078 description "مقالة علمية نشرت في 10 نوفمبر 2020" @default.
- Q103004078 description "১০ নভেম্বর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q103004078 description "บทความทางวิทยาศาสตร์" @default.
- Q103004078 description "სამეცნიერო სტატია" @default.
- Q103004078 name "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 name "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 name "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 type Item @default.
- Q103004078 label "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 label "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 label "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 prefLabel "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 prefLabel "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 prefLabel "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 P1433 Q103004078-8C180B32-B5A6-468D-B191-C12DFA2008D3 @default.
- Q103004078 P1476 Q103004078-DEB98090-EE7C-469B-8EBB-5DB08E88ADCF @default.
- Q103004078 P2093 Q103004078-1931CADA-6B0F-437F-B659-B0A72C320D8C @default.
- Q103004078 P2093 Q103004078-37030B28-8F56-4070-910B-EDC9C7A3E6E7 @default.
- Q103004078 P2093 Q103004078-3DBB370E-3588-4BDB-9CB6-F632D6BD0FBA @default.
- Q103004078 P2093 Q103004078-5920866E-D2C9-422C-BD97-C63843B615C9 @default.
- Q103004078 P2093 Q103004078-5A18B1F2-B4E6-47D7-830C-013A5FE88949 @default.
- Q103004078 P2093 Q103004078-6E3E176E-C9E9-4726-B5CC-524C86A9B825 @default.
- Q103004078 P2093 Q103004078-97C3D524-0B74-4E48-A677-6AB33595F8BF @default.
- Q103004078 P2093 Q103004078-D1329866-90BB-40A8-A17B-D1EE85A59738 @default.
- Q103004078 P2093 Q103004078-E7CA54E0-BDE0-4537-94AA-B38F3A683807 @default.
- Q103004078 P275 Q103004078-1e3e7796-cffd-4e10-951a-216b0517690a @default.
- Q103004078 P2860 Q103004078-6C9490FC-E291-4A82-975D-1D0249DF3A3A @default.
- Q103004078 P304 Q103004078-3BBCAC9E-AFAD-4815-AD2C-7787FAC9E9EC @default.
- Q103004078 P31 Q103004078-7126CE92-F1E2-473E-8279-870544F50DB7 @default.
- Q103004078 P356 Q103004078-F67998F7-0688-4DB0-B149-D2B550F31972 @default.
- Q103004078 P478 Q103004078-565E3656-2C5C-45D2-BE50-302DD8394B13 @default.
- Q103004078 P577 Q103004078-38AD12A4-8410-497D-A52E-062D5E5BD6DA @default.
- Q103004078 P6216 Q103004078-89354a07-f327-4e1f-874c-7f05c99472ff @default.
- Q103004078 P698 Q103004078-D9263391-E166-4497-89F5-866FBBC52521 @default.
- Q103004078 P921 Q103004078-D3A12C7E-515B-48F7-B39B-24008732E465 @default.
- Q103004078 P932 Q103004078-D1E6AF90-EAC2-4995-BD98-E44FE5B4C50D @default.
- Q103004078 P356 FPHAR.2020.594321 @default.
- Q103004078 P698 33244300 @default.
- Q103004078 P1433 Q2681208 @default.
- Q103004078 P1476 "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure" @default.
- Q103004078 P2093 "Cemal Orhan" @default.
- Q103004078 P2093 "Fatih M Uckun" @default.
- Q103004078 P2093 "Hendrik van Wyk" @default.
- Q103004078 P2093 "Ibrahim H Ozercan" @default.